Clinical Trial Update: PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update comparing PASCAL laser versus ETDRS laser in combination with intravitreal ranibizumab, versus ranibizumab alone, for pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: University of Sao Paulo | Conditions: Proliferative Diabetic Retinopathy | Phase 4 | Status: UNKNOWN